Latest 8-K filings

PodcastOne, Inc. held its 2026 Annual Meeting of Stockholders, where all director nominees were elected and shareholders approved an increase in the equity incentive plan shares and ratified the appointment of its independent auditor.

Waste Energy Corp. announced the successful approval by its stockholders of an amendment to increase authorized common shares from 400 million to 1.6 billion.

Fifth Third Bancorp announced the successful expiration and results of its registered exchange offer for outstanding unregistered senior notes.

FMC Corporation announced the closing of a minority equity investment by Tessenderlo Group, which now holds approximately 20.0% of FMC's outstanding common stock.

Raymond James Financial announced record assets under administration of $1.97 trillion for August 2026, marking a 16% year-over-year increase.

Bath & Body Works, Inc. announced a performance stock unit award valued at $10 million for CEO Daniel Heaf, tied to rigorous stock price hurdles and total shareholder return.

Braemar Hotels & Resorts Inc. has announced the postponement of its 2026 Annual Meeting of Stockholders, rescheduling it from November 13, 2026, to December 21, 2026.

Teamshares Inc. announced the closing of a $225 million preferred equity investment to bolster its programmatic acquisition strategy, with an option for an additional $75 million.

Jacobs Solutions Inc. files an amendment to its Form 8-K detailing modifications to the separation agreement for former President Shannon Miller, outlining severance benefits and continued vesting schedules.

Clarivate Plc has announced the pricing terms for a cash tender offer by its subsidiary, Clarivate Science Holdings Corporation, to purchase certain outstanding debt securities.

Theravance Biopharma, Inc. announced the completion of its merger with Zymeworks Inc., with shareholders receiving $17.00 in cash and a contingent value right per share.

Solaris Energy Infrastructure, Inc. announced the pricing of an upsized $1.25 billion offering of 7.000% Senior Notes due 2032, with net proceeds intended for general corporate purposes and growth capital expenditures.

Farmers and Merchants Bancshares, Inc. has elected Mark C. Krebs, former Treasurer and CFO, to its Board of Directors, effective September 21, 2026.

Orange County Bancorp, Inc. presented its second quarter 2026 results, showcasing continued strong financial performance, strategic expansion, and a robust deposit-gathering strategy.

NeoVolta announced fiscal year 2026 results with 58% revenue growth to $13.3 million, but a sharp Q4 decline in residential sales, increased net loss, and negative EBITDA, while highlighting progress in its utility-scale BESS manufacturing and SK On collaboration.

Jazz Pharmaceuticals plc announces an amendment to its credit agreement, extending the maturity of a significant term loan facility and repricing its interest rates.

HealthStream, Inc. announced the approval of special grants of restricted share units (RSUs) to its named executive officers to incentivize future performance and retention.

Arcturus Therapeutics announced encouraging interim Phase 2 results for ARCT-810 in OTC deficiency and introduced its next-generation LUNAR 2.0 mRNA delivery platform, alongside plans to acquire AI discovery company myNEO.

Ready Capital Corporation has executed a First Supplement to its Eighth Supplemental Indenture, amending covenants for its 7.375% Senior Notes due 2027 with bondholder consent.

VSee Health, Inc. has filed a Form 8-K announcing a 1-for-80 reverse stock split of its common stock, effective September 23, 2026, to adjust its issued shares.

Visa Inc. has deposited $405 million into a U.S. litigation escrow account, triggering downward adjustments to conversion rates for its Class B-1, B-2, and B-3 common stock, impacting share counts and earnings per share.

Galaxy Digital Inc. announced the appointment of Dritan Muneka as its new Principal Accounting Officer, effective September 30, 2026, following Robert Rico's resignation.

Zymeworks Inc. has finalized its acquisition of Theravance Biopharma, funded by a $350 million senior secured notes issuance, and introduced contingent value rights for Theravance shareholders.

MariMed Inc. has filed a definitive proxy statement seeking stockholder approval for a reverse stock split to meet U.S. national exchange listing requirements.

Gossamer Bio announced the submission of its first New Drug Application (NDA) to the FDA for seralutinib, a treatment for pulmonary arterial hypertension (PAH), marking a key regulatory step.

Evommune, Inc. announced the late-breaker presentation of Phase 2a data for its EVO301 drug candidate in moderate-to-severe atopic dermatitis at the EADV Congress.

Longeveron Inc. announced topline results from its Phase 2b ELPIS II clinical trial for hypoplastic left heart syndrome (HLHS) which did not meet its primary efficacy endpoint.

Stitch Fix announced its fourth quarter and full fiscal year 2026 financial results, reporting revenue growth but a decline in active clients, with a cautious outlook for fiscal year 2027.

Central Plains Bancshares, Inc. announced the extension of employment and change in control agreements for its President & CEO, EVP & CFO, and EVP & Chief Lending Officer.

Apogee Enterprises, Inc. has finalized the acquisition of SIA GroGlass, a Latvian company specializing in high-performance glass coatings, for up to approximately $71.8 million.